Not Yet RecruitingNot Applicable

Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders

20 participantsStarted 2024-08-10

Plain-language summary

To investigate the safety and efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: A- diffuse and Nodular goiter: B-Toxic goiter: C-Thyroid cancer: Exclusion Criteria: A. Significant bleeding diathesis. B. Contraindication for contrast media (renal impairment or allergy). C. Severe atherosclerotic disease prevent arterial catheterization. D. Refusal of signing a consent

What they're measuring

To investigate the safety of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders

Timeframe: Up to 12 months follow up after embolization

To investigate the efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders

Timeframe: Up to 12 months follow up after embolization

Trial details

NCT IDNCT06537141

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-09

View on ClinicalTrials.gov More Graves Disease trials